Review of Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors | Publons

Log in Register

Post-publication Review of

Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors

Reviewed On March 21, 2019

Reviewed by

Actions

Content of review 1, reviewed on March 21, 2019

Coming

Source

© 2019 the Reviewer (CC BY 4.0).